These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 14871832)

  • 1. Semaphorin-3F is an inhibitor of tumor angiogenesis.
    Kessler O; Shraga-Heled N; Lange T; Gutmann-Raviv N; Sabo E; Baruch L; Machluf M; Neufeld G
    Cancer Res; 2004 Feb; 64(3):1008-15. PubMed ID: 14871832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesis.
    Dhanabal M; Wu F; Alvarez E; McQueeney KD; Jeffers M; MacDougall J; Boldog FL; Hackett C; Shenoy S; Khramtsov N; Weiner J; Lichenstein HS; LaRochelle WJ
    Cancer Biol Ther; 2005 Jun; 4(6):659-68. PubMed ID: 15917651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.
    Guttmann-Raviv N; Shraga-Heled N; Varshavsky A; Guimaraes-Sternberg C; Kessler O; Neufeld G
    J Biol Chem; 2007 Sep; 282(36):26294-305. PubMed ID: 17569671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
    Yeh CH; Peng HC; Yang RS; Huang TF
    Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
    Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Segregation of arterial and venous markers in subpopulations of blood islands before vessel formation.
    Herzog Y; Guttmann-Raviv N; Neufeld G
    Dev Dyn; 2005 Apr; 232(4):1047-55. PubMed ID: 15739224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
    Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
    Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bastadin 6, a spongean brominated tyrosine derivative, inhibits tumor angiogenesis by inducing selective apoptosis to endothelial cells.
    Aoki S; Cho SH; Ono M; Kuwano T; Nakao S; Kuwano M; Nakagawa S; Gao JQ; Mayumi T; Shibuya M; Kobayashi M
    Anticancer Drugs; 2006 Mar; 17(3):269-78. PubMed ID: 16520655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semaphorin signaling in vascular and tumor biology.
    Neufeld G; Lange T; Varshavsky A; Kessler O
    Adv Exp Med Biol; 2007; 600():118-31. PubMed ID: 17607951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.
    Mendel DB; Schreck RE; West DC; Li G; Strawn LM; Tanciongco SS; Vasile S; Shawver LK; Cherrington JM
    Clin Cancer Res; 2000 Dec; 6(12):4848-58. PubMed ID: 11156244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases.
    Varshavsky A; Kessler O; Abramovitch S; Kigel B; Zaffryar S; Akiri G; Neufeld G
    Cancer Res; 2008 Sep; 68(17):6922-31. PubMed ID: 18757406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glyceollins, a novel class of soy phytoalexins, inhibit angiogenesis by blocking the VEGF and bFGF signaling pathways.
    Lee SH; Lee J; Jung MH; Lee YM
    Mol Nutr Food Res; 2013 Feb; 57(2):225-34. PubMed ID: 23229497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway.
    Hata Y; Rook SL; Aiello LP
    Diabetes; 1999 May; 48(5):1145-55. PubMed ID: 10331422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells.
    Kigel B; Varshavsky A; Kessler O; Neufeld G
    PLoS One; 2008 Sep; 3(9):e3287. PubMed ID: 18818766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endostar attenuates melanoma tumor growth via its interruption of b-FGF mediated angiogenesis.
    Xiao L; Yang S; Hao J; Yuan X; Luo W; Jiang L; Hu Y; Fu Z; Zhang Y; Zou C
    Cancer Lett; 2015 Apr; 359(1):148-54. PubMed ID: 25597785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
    Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
    J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.